For research use only. Not for therapeutic Use.
Clopidogrel (Item No. <span class=/itemid/>13657</span>) is an antithrombic compound whose active metabolite is a selective, irreversible antagonist of the platelet purinergic P2Y<sub>12</sub> receptor (IC<sub>50</sub> = 100 nM). Clopidogrel inhibits ADP-induced platelet aggregation <em>ex vivo</em> and functions as a prodrug whereupon biotransformation to its active thiol metabolite <em>via</em> CYP2C19 in the liver enables its anti-aggregating activity. An estimated 15% of administered clopidogrel is metabolized by CYP2C19 to the thiol metabolite. Clopidogrel carboxylic acid is a major inactive metabolite of clopidogrel. Most (85%) of circulating clopidogrel is hydrolyzed by esterases to this carboxylic acid form. This inactive metabolite can be used as a reference standard for quantitative analysis of clopidogrel metabolism.
Catalog Number | R018066 |
CAS Number | 144750-42-5 |
Synonyms | (S)-α-(2-Chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic Acid Hydrochloride; SR 26334 Hydrochloride |
Molecular Formula | C15H15Cl2NO2S |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetic acid;hydrochloride |
InChI | InChI=1S/C15H14ClNO2S.ClH/c16-12-4-2-1-3-11(12)14(15(18)19)17-7-5-13-10(9-17)6-8-20-13;/h1-4,6,8,14H,5,7,9H2,(H,18,19);1H/t14-;/m0./s1 |
InChIKey | FOKSIOUPGDBSLC-UQKRIMTDSA-N |
SMILES | C1CN(CC2=C1SC=C2)C(C3=CC=CC=C3Cl)C(=O)O.Cl |